Equitable Trust Co. Invests $417,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Equitable Trust Co. acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,030 shares of the company's stock, valued at approximately $417,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of HSIC. Cromwell Holdings LLC increased its holdings in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after acquiring an additional 170 shares during the last quarter. Versant Capital Management Inc grew its stake in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after buying an additional 335 shares during the last quarter. City State Bank acquired a new position in Henry Schein during the 4th quarter worth $55,000. Farther Finance Advisors LLC boosted its position in Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after acquiring an additional 346 shares during the period. Finally, Mather Group LLC. boosted its position in Henry Schein by 43.7% during the 4th quarter. Mather Group LLC. now owns 1,503 shares of the company's stock worth $104,000 after acquiring an additional 457 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

NASDAQ:HSIC traded down $1.62 during mid-day trading on Friday, hitting $76.00. 1,455,207 shares of the company's stock traded hands, compared to its average volume of 1,474,978. The firm has a 50 day moving average of $74.01 and a two-hundred day moving average of $72.00. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The firm has a market capitalization of $9.48 billion, a price-to-earnings ratio of 31.28, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price on the stock. Barrington Research upped their price target on Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a research report on Thursday, January 30th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Finally, Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and upped their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Eight equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $80.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.